2nd Edition

Handbook of Harnessing Biomaterials in Nanomedicine
Preparation, Toxicity, and Applications



  • Available for pre-order. Item will ship after December 31, 2020
ISBN 9789814800907
December 31, 2020 Forthcoming by Jenny Stanford Publishing
350 Pages

USD $179.95

Prices & shipping based on shipping country


Preview

Book Description

Nanomedicine has emerged as a novel field in medicine integrating nano-scale technologies with materials sciences, chemistry and biology. The medical application of nanotechnology has the potential to revolutionize diagnosis and therapy and bring this new field from a notion into reality while impacting the lives of millions around the world. This second edition compiles and details the latest cutting-edge research in science and medicine from the interdisciplinary standpoint who are currently revolutionizing drug delivery techniques through the development of nanomedicines. Edited by Dan Peer, a prominent bio-nanotechnologiest, this book will attract anyone involved materials sciences, chemistry, biology and medicine that would like to design applications in the medical field of nanotechnology towards cancer therapy, inflammation, viral infection, imaging and toxicity.

Table of Contents

1. Biomaterial-based particulate drug carriers, Rimona Margalit
2. Single -Chain Polymer, Iraida Loinaz
3. Polyethelene Glycol Polyester, Laird Forrest
4. Recent progress in Polymer, Ronit Satchi-Fainaro
5. Polysaccharides as nanomaterials for Therapeutics, Dan Peer
6. RNAi as new class of Nanomedicines, Derek M. Dykxhoorn
7. Novel RNA interference (RNAi-based Nanomedicines, Priti Kumar
8. Barcodes, Avi Schroder
9. Detection and description of, Alan Packard
10. Imaging, Paolo Decuzzi
11. Image based high content analysis, Miguel Weil
12. Albumin, Kenneth Howard
13. Wrong Resemblance, Thomas Vorup-Jensen
14. Complement activation, Janos Szebeni
15. Doxil, Y. Barenholz

...
View More

Editor(s)

Biography

Dan Peer is a is a Full Professor and the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). From 2016, he is the Chair of Tel Aviv University Cancer Biology Research Center; the biggest Cancer Center in Israel that includes 17 affiliated hospitals and from 2017, the Founding and Managing Director of SPARK Tel Aviv, Center for Translational Medicine at TAU. From Oct. 2020 he will become the Vice President for Research and Development of Tel Aviv University.